These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7094989)

  • 1. The influence of blood collection technique on serum and plasma protein binding of disopyramide.
    Haughey DB; Lima JJ
    Eur J Clin Pharmacol; 1982; 22(2):185-9. PubMed ID: 7094989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.
    Lima JJ; Boudoulas H; Blanford M
    J Pharmacol Exp Ther; 1981 Dec; 219(3):741-7. PubMed ID: 7299695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma protein binding of disopyramide by equilibrium dialysis and ultrafiltration.
    David BM; Tjokrosetio R; Ilett KF
    Ther Drug Monit; 1983; 5(1):81-6. PubMed ID: 6845403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative binding of disopyramide phosphate and quinidine sulfate to human plasma proteins.
    Chien YW; Lambert HJ; Karim A
    J Pharm Sci; 1974 Dec; 63(12):1877-9. PubMed ID: 4449018
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of concentration-dependent plasma protein binding in disopyramide disposition.
    Meffin PJ; Robert EW; Winkle RA; Harapat S; Peters FA; Harrison DC
    J Pharmacokinet Biopharm; 1979 Feb; 7(1):29-46. PubMed ID: 458555
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of unbound fraction of disopyramide in plasma: a comparison of equilibrium dialysis, ultrafiltration through dialysis membranes and ultrafree anticonvulsant drug filters.
    Norris RL; Ahokas JT; Ravenscroft PJ
    J Pharmacol Methods; 1982 Jan; 7(1):7-14. PubMed ID: 7070107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction.
    David BM; Ilett KF; Whitford EG; Stenhouse NS
    Br J Clin Pharmacol; 1983 Apr; 15(4):435-41. PubMed ID: 6849779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma binding of disopyramide.
    David BM; Madsen BW; Ilett KF
    Br J Clin Pharmacol; 1980 Jun; 9(6):614-8. PubMed ID: 7387819
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereoselective binding of disopyramide to human plasma protein.
    Lima JJ; Jungbluth GL; Devine T; Robertson LW
    Life Sci; 1984 Aug; 35(8):835-9. PubMed ID: 6482678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma binding of disopyramide and mono-N-dealkyldisopyramide.
    Bredesen JE; Pike E; Lunde PK
    Br J Clin Pharmacol; 1982 Nov; 14(5):673-6. PubMed ID: 7138747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of disopyramide enantiomers for sites on plasma protein.
    Lima JJ
    Life Sci; 1987 Dec; 41(26):2807-13. PubMed ID: 3695808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma protein binding of disopyramide in pregnant and postpartum women, and in neonates and their mothers.
    Echizen H; Nakura M; Saotome T; Minoura S; Ishizaki T
    Br J Clin Pharmacol; 1990 Apr; 29(4):423-30. PubMed ID: 2183867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intra-individual change in serum protein binding on the pharmacologic response of R- and S-disopyramide in the rabbit.
    Huang JD; Oie S
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):243-53. PubMed ID: 6635319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetic and pharmacodynamic effects of varying the free fraction of disopyramide.
    Shaw LM; Doherty JU; Waxman HL; Josephson ME
    Angiology; 1987 Feb; 38(2 Pt 2):192-7. PubMed ID: 3826754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of concentration-dependent protein binding on serum concentrations and urinary excretion of disopyramide and its metabolite following oral administration.
    Haughey DB; Lima JJ
    Biopharm Drug Dispos; 1983; 4(2):103-12. PubMed ID: 6882879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Displacement of lidocaine from human plasma proteins by disopyramide.
    Bonde J; Jensen NM; Burgaard P; Angelo HR; Graudal N; Kampmann JP; Pedersen LE
    Pharmacol Toxicol; 1987 Feb; 60(2):151-5. PubMed ID: 3575249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein binding of disopyramide--displacement by mono-N-dealkyldisopyramide and variation with source of alpha-1-acid glycoprotein.
    Haughey DB; Steinberg I; Lee MH
    J Pharm Pharmacol; 1985 Apr; 37(4):285-8. PubMed ID: 2860235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of protein binding on disopyramide clearance.
    Bryson SM; Lawrence JR; Steele WH; Campbell BC; Elliott HL; Sumner DJ
    Eur J Clin Pharmacol; 1982; 23(5):453-6. PubMed ID: 7151851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered protein binding of disopyramide in plasma from patients with cancer and with inflammatory disease.
    Echizen H; Saima S; Umeda N; Ishizaki T
    Ther Drug Monit; 1987 Sep; 9(3):272-8. PubMed ID: 3672569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite.
    Hinderling PH; Bres J; Garrett ER
    J Pharm Sci; 1974 Nov; 63(11):1684-90. PubMed ID: 4427225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.